|
Main | | | | | | | | | |
| Brand Name | Generic Name | Indication | Economics | Approval | MOA | Competition | NDA | Admin |
| Cayston | aztreonam lysine | Cystic Fibrosis | 1 | 2/22/2010 | Inhaled Antibiotic | TOBI | | |
| Epclusa | sofosbuvir; velpatasvir | HCV | 1 | | | | | |
| Flolan | | PAH | GSK | 9/20/1995 | | | | |
| Genvoya | cobicistat; elvitegravir; emtricitabine; TAF | HIV | | | | | | |
| Stribild | cobicistat; elvitegravir; emtricitabine; TDF | HIV | | | | | | |
| Tybost | cobicistat | PK Booster | | | | 203094 | | |
| Vitekta | elvitegravir | HIV | | | | | | |
| Vosevi | velpatasvir; sofosbuvir; voxilaprevir | HCV | 1 | | | | | |
| Ranexa | Angina | 1 | | CCBs | XR patent | | | |
| Truvada (tenofovir/emtricitabine) | HIV | 1 | 2/8/2004 | Combivir | 2017+ | | | |
| Viread (tenofovir) | HIV, HBV | 1 | 10/26/2001 | Combivir | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| GS9620 | | | | | | | | |
| GS9260 | | | | | | | | |
| GS9411 (not listed on pipeline chart) | Cystic Fibrosis | Parion | I | Sodium Channel | | | | |
| GS9310/11 | CF/COPD | 1 | II | Fosfomycin/TOBI | TOBI | | | |
| GS9190 (tegobuvir) | HCV | 1 | II | non-nucleoside PI | | | | |